WINSTON-SALEM, N.C., Nov. 20, 2026 — Primary care clinicians who recognized opioid misuse in their patients did not always record it in the medical record, according to a national survey of 1,470 clinicians led by researchers at Wake Forest University School of Medicine .
Nearly nine in 10 clinicians surveyed (87.3%) said they had identified opioid misuse in at least one patient during the previous year. About six in 10 (61.2%) said they had recorded it in a patient's medical record. The 26-percentage-point difference reflects a gap within the same clinicians' own practice, not a difference between clinicians who notice misuse and those who do not. The gap was similar among physicians, nurse practitioners and physician assistants across practice settings. The findings raise questions about whether medical records fully capture opioid misuse that clinicians identify.
The findings were published today in JAMA Health Forum.
The survey asked about opioid misuse, including taking opioids for the feeling of being high. Misuse is distinct from opioid use disorder. Misuse is a behavior, not a diagnosis. Opioid use disorder is medical condition marked by craving, loss of control and continued use despite harm, but misuse often comes first.
"This study shows that what clinicians recognize in caring for their patients doesn't always make it into the medical record," said Robert W. Hurley, M.D., Ph.D ., corresponding author, director of the pain outcomes lab, and professor of pain medicine and anesthesiology at Wake Forest University School of Medicine. "Opioid misuse often comes before opioid use disorder or an overdose. When a clinician recognizes that early signal but it never reaches the chart, the next clinician who sees that patient starts without it, and the public health systems that rely on medical records never see it at all."
A national survey of primary care clinicians
Researchers surveyed 1,470 U.S. primary care physicians, nurse practitioners and physician assistants who had prescribed opioids during the previous year.
Conducted in April and May 2025 through a national online panel of clinicians, the survey asked whether clinicians had identified opioid misuse in the previous 12 months, how they recorded it and what made recording it difficult. The questionnaire was refined through feedback from clinicians affiliated with the American Medical Association Substance Use and Pain Care Task Force, who participated in a personal capacity.
Why wasn't misuse always recorded?
Clinicians cited several barriers, including concerns about stigma, time pressures and difficulties fitting documentation into their work. The most common concern, reported by 38.5%, was that recording opioid misuse could lead to a patient being judged or treated differently.
However, clinicians who reported barriers were no more likely to have recognized misuse without documenting it than clinicians who reported no barriers.
"We expected the barriers clinicians described might help explain who was most likely to recognize misuse but leave it undocumented, but that wasn't what we found," Hurley said. "This is also not simply a terminology problem. We asked about the clinical term clinicians put in the record. Clinicians recognized misuse and had a way to record it, and a sizable share still did not."
Why it matters and what comes next
Medical records help guide patient care and allow researchers and public health officials to track opioid misuse. The next step is to compare what clinicians tell us with what is actually in the electronic health record, so we can understand how much recognized misuse is missing and what is driving the gap.
The study relied on clinicians' recollections rather than a review of patients' medical records, so it cannot show how often opioid misuse went unrecorded. Participants came from an online panel and may not represent all U.S. primary care clinicians. The survey also may have missed other terms clinicians used to record misuse.
The research was supported by the National Institutes of Health HEAL Initiative and the National Institute on Drug Abuse through grants R24DA055306, R24DA058606, U24DA057612 and R01DA058640.
About Wake Forest University School of Medicine
Wake Forest University School of Medicine is the academic core of Charlotte, North Carolina-based Advocate Health and a recognized leader in experiential medical education and groundbreaking research. It directs the education of nearly 1,900 students and fellows, including physicians, basic scientists and allied clinical professionals. The school of medicine also strategically investigates opportunities that will expand basic and clinical research, resulting in nationally and internationally recognized excellence in biomedical research. The school has two campuses, each co-located with leading-edge innovation districts, The Pearl , in Charlotte, and Innovation Quarter , in Winston-Salem, North Carolina. These affiliated life-sciences innovation districts focus on advancing health care through new medical technologies and biomedical discovery.
About Advocate Health
Headquartered in Charlotte, North Carolina, Advocate Health is the third-largest nonprofit, integrated health system in the United States. A preeminent academic health system at the forefront of clinical excellence, innovation and research, it delivers care under the names Advocate Health Care in Illinois; Atrium Health in the Carolinas, Georgia and Alabama; and Aurora Health Care in Wisconsin and Michigan, and Wake Forest University School of Medicine